Myriad Defends Patent Claims on Genetic Material in Court Case

Myriad Genetics Inc., owner of patents related to genes linked to hereditary cancer risks, is trying to claim legal ownership of a product of nature, the American Civil Liberties Union told a U.S. appeals court today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.